Cargando…
Quantitative DNA Methylation Analysis of DLGAP2 Gene using Pyrosequencing in Schizophrenia with Tardive Dyskinesia: A Linear Mixed Model Approach
Tardive dyskinesia (TD) is a side effect of antipsychotic medications used to treat schizophrenia (SCZ) and other mental health disorders. No study has previously used pyrosequencing to quantify DNA methylation levels of the DLGAP2 gene; while the quantitative methylation levels among CpG sites with...
Autores principales: | Li, Yanli, Wang, Kesheng, Zhang, Ping, Huang, Junchao, An, Huimei, Wang, Nianyang, De Yang, Fu, Wang, Zhiren, Tan, Shuping, Chen, Song, Tan, Yunlong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6269460/ https://www.ncbi.nlm.nih.gov/pubmed/30504779 http://dx.doi.org/10.1038/s41598-018-35718-4 |
Ejemplares similares
-
Pyrosequencing analysis of IRS1 methylation levels in schizophrenia with tardive dyskinesia
por: Li, Yanli, et al.
Publicado: (2020) -
Altered DNA methylation of CYP2E1 gene in schizophrenia patients with tardive dyskinesia
por: Zhang, Ping, et al.
Publicado: (2022) -
Decreased Gray Matter Volume of Cuneus and Lingual Gyrus in Schizophrenia Patients with Tardive Dyskinesia is Associated with Abnormal Involuntary Movement
por: Yu, Ting, et al.
Publicado: (2018) -
5-Hydroxytryptamine Receptors and Tardive Dyskinesia in Schizophrenia
por: Pozhidaev, Ivan V., et al.
Publicado: (2020) -
Genome wide study of tardive dyskinesia in schizophrenia
por: Lim, Keane, et al.
Publicado: (2021)